Recommendation Impact Statement The recommendation to remove the current claiming restrictions on these diagnostic services will benefit patients as it will allow practitioners to provide specific therapeutic services during the same episode of care. This will mean that patients will not be required to undergo a second sedation. Table 21: Current Endoscopic Ultrasound items Service Schedule Services Change Item Item Descriptor Fee 2014–15 2011–12 to 2014–15 30688 ENDOSCOPIC ULTRASOUND (endoscopy with $364.90 1,545 19% ultrasound imaging), with or without biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) 30690 ENDOSCOPIC ULTRASOUND (endoscopy with $563.30 779 -6% ultrasound imaging), with or without biopsy, WITH FINE NEEDLE ASPIRATION, including aspiration of the locoregional lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) 30692 ENDOSCOPIC ULTRASOUND (endoscopy with $364.90 3,085 40% ultrasound imaging), with or without biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) 30694 ENDOSCOPIC ULTRASOUND (endoscopy with $563.30 1,689 61% ultrasound imaging), with or without biopsy, WITH FINE NEEDLE ASPIRATION for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) Source: Publicly available MBS Data (Department of Human Services website)
Recommendation Impact Statement The recommendation to remove the current claiming restrictions on these diagnostic services will benefit patients as it will allow practitioners to provide specific therapeutic services during the same episode of care. This will mean that patients will not be required to undergo a second sedation. Table 21: Current Endoscopic Ultrasound items Item Item Descriptor Schedule Fee Services 2014–15 Service Change 2011–12 to 2014–15 30688 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) $364.90 1,545 19% 30690 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, WITH FINE NEEDLE ASPIRATION, including aspiration of the locoregional lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) $563.30 779 -6% 30692 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) $364.90 3,085 40% 30694 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, WITH FINE NEEDLE ASPIRATION for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. (Anaes.) $563.30 1,689 61% Source: Publicly available MBS Data (Department of Human Services website)